{"schema_version":"secwatch.filing_event.v1","accession":"0000885725-24-000014","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.145081+00:00","generated_at":"2026-06-06T14:29:30.904686+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Boston Scientific appoints Jonathan Monson as SVP Investor Relations; Emily Woodworth as CAO","bullets":["Jonathan Monson appointed SVP Investor Relations effective March 1, 2024; will no longer serve as Chief Accounting Officer.","Emily Woodworth (Collins) appointed SVP Global Controller and CAO effective March 1, 2024; previously VP Finance and Controller of Urology business.","Woodworth will receive base salary, annual bonus, and incentive stock awards commensurate with officer level."],"urls":{"canonical":"https://secwatch.observer/filing/0000885725-24-000014","json":"https://secwatch.observer/filing/0000885725-24-000014.json","markdown":"https://secwatch.observer/filing/0000885725-24-000014.md","text":"https://secwatch.observer/filing/0000885725-24-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/0000885725-24-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/bsx-20240126.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T14:29:30.904686+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9031c929c4","claim":"Emily Woodworth (Collins) was appointed as Senior Vice President, Global Controller and Chief Accounting Officer at BOSTON SCIENTIFIC CORP.","evidence_excerpt":"Also on January 26, 2024, the Board appointed Emily Woodworth (Collins), age 46, as Senior Vice President, Global Controller and Chief Accounting Officer, effective March 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/0000885725-24-000014-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Global Controller and Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"fc742b254c","claim":"Jonathan Monson was appointed as Senior Vice President, Investor Relations at BOSTON SCIENTIFIC CORP.","evidence_excerpt":"On January 26, 2024, the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) appointed Jonathan Monson as Senior Vice President, Investor Relations, effective March 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/0000885725-24-000014-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Investor Relations"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}